FDA’s approach to risk management for Vivus Inc.’s weight-loss therapy Qnexa, a combination of phentermine and topiramate, reflects concern about affecting medical use of the two components, which currently are marketed individually.
Topiramate is available as Janssen Pharmaceuticals Inc.’s Topamax and generics to treat epilepsy and for migraine prophylaxis, while phentermine...